Tag: Episodic migraine

According to a systematic review from 2021, levetiracetam can significantly reduce the frequency and severity of migraines in both adult and pediatric patients. This places **levetiracetam** as a potential therapeutic option for migraine prophylaxis, though it is not a first-line choice like some other antiepileptic drugs.

Affecting more than 39 million Americans, migraines are a debilitating condition for which many seek long-term solutions. For those considering this treatment, a key question is: **how long can you be on Qulipta?** This medication is designed for long-term preventive use.

Affecting nearly 40 million people in the United States, migraine is a complex neurological disease. For those seeking preventive treatment, a common question is: **How long does Qulipta take to kick in?** This daily oral medication can show effects sooner than many expect.

Migraine affects nearly 40 million people in the United States alone, making effective preventive treatment essential. When considering modern options, a key question arises for many: is Ajovy or Qulipta better for preventing these debilitating headaches?